Patients with intermediate coronary syndrome face a 16.7% risk of major adverse cardiac events within 2 months, with the highest risk concentrated in the first 3 weeks.
No takes yet. Share an insight, caveat, or question.
Signals need for vigilant early follow-up after intermediate coronary syndrome; leaves open optimal strategies pending randomized trials.
O Skjaeggestad (1973) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: